Spitzer’s week: Wall Street piles on

It wasn’t a good week for the already tattered legacy of Eliot Spitzer, and no, we’re not talking about the tabloid headlines about the latest exploits of his sometime paramour Ashley Dupre.
For one thing, the lawsuit against former American International Group CEO Maurice “Hank” Greenberg, one of Spitzer’s highest profile prosecutions as New York Attorney general, looks a […]

What a Week: Celluloid Heroes Can’t Save U.S. Economy

The market began this week basking in the afterglow of last week’s big rally in financials, but the unrelenting housing crisis kept challenging the optimism.

Morgan Stanley goofs Brookfield

Morgan Stanley’s money managers, entrusted with navigating the world’s financial markets with all kinds of sophisticated strategies, evidently have a little problem with long division.
On Thursday the big Wall Street bank announced that its investment management division snapped up a bigger stake in Brookfield Infrastructure Partners (BIP) than intended. Nearly twice as much.
Morgan received shares of […]

“Pretty Big Downside” for Oil, Energy Stocks as Demand Falls, Garnick Says

Following a rapid, 15% drop from their recent peak, oil prices stabilized around $125 per barrel for a few days but were declining again on Friday.Numerous reports of oil’s demise have proven premature in the recent years. But “as global GDP slows do

Sphere: Related Content

Garnick: More Inventory Coming, $1 Trillion Minimum Cost of Housing Crisis

Are we finally seeing some rays of light in the deep, dark housing abyss?New home sales fell a less-than-expected 0.6% in June, the Commerce Department said Friday and the

Invesco’s Garnick “Very Scared to Buy Financials,” Citing Book Value Mystery

Fears Thursday’s selloff would lead to another rout ebbed early Friday thanks to a stronger-than-expected durable goods report. …

What will Roche end up paying for Genentech?

The first lawsuits are flying but Roche’s experienced dealmakers are unlikely to put more cash on the table just yet.
While it seems clear $89 a share won’t do it – the market has already pushed Genentech stock to $95 and some analysts are talking well over $100 – the Basel-based drugs giant can afford to bide its time. With 56 percent of the […]

GM navigates offshore roads

GM has had a rough few weeks, with its share price racing down hill and increasingly frequent questions about solvency. So we note with interest the second sign in two days that the auto giant is looking to pump up its position in higher growth markets abroad. Russian car maker GAZ said today it plans […]

Next Page »